| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 7,196 | 6,853 | 6,902 | 7,028 | | Cost of Revenue | 3,083 | 3,223 | 3,097 | 3,230 | | | Gross Profit | 4,113 | 3,630 | 3,805 | 3,798 | | | Operating Expenses | | Research Development | 752 | 820 | 663 | 746 | | Selling General and Administrative | 3,642 | 3,524 | 3,720 | 3,611 | | Non Recurring |
-
|
-
|
-
| 4,144 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (281) | (714) | (578) | (4,703) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (5) |
-
| 5 | 23 | | Earnings Before Interest And Taxes | (290) | (714) | (573) | (4,680) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (290) | (714) | (573) | (4,680) | | Income Tax Expense | 1 | 20 | (12) | 7,804 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (291) | (734) | (561) | (12,484) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (291) | (734) | (561) | (12,484) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($291) | ($734) | ($561) | ($12,484) |
|
0.51% Nasdaq 
Income Statement
